Chime director-linked funds sell 447K shares
Director-linked investment funds sold 447,637 CHYM shares in mid-September 2026 while retaining significant indirect and direct holdings.
Rhea-AI Filing Summary
Chime Financial, Inc. (CHYM) director James Feuille reported that investment entities and trusts associated with him sold a total of 447,637 shares of Class A Common Stock between September 14 and September 16, 2026 in open-market transactions at weighted-average prices within disclosed ranges. Following these trades and prior exempt in-kind fund distributions, he continues to report indirect holdings through Crosslink funds and trusts, plus 23,315 shares held directly, while disclaiming beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F5, F2 | 62,218 | $31.46 | $1.96M |
| Sale | Class A Common Stock F6, F2 | 33,182 | $32.19 | $1.07M |
| Sale | Class A Common Stock F7, F8, F9, F10 | 161,437 | $32.70 | $5.28M |
| Sale | Class A Common Stock F4, F2 | 94,446 | $33.20 | $3.14M |
| Sale | Class A Common Stock F2 | 954 | $33.95 | $32K |
| Sale | Class A Common Stock F1, F2 | 93,428 | $34.08 | $3.18M |
| Sale | Class A Common Stock F3, F2 | 1,972 | $34.41 | $68K |
| holding | Class A Common Stock F11, F12 | -- | -- | -- |
| holding | Class A Common Stock F13, F14 | -- | -- | -- |
| holding | Class A Common Stock F15, F16 | -- | -- | -- |
| holding | Class A Common Stock F17, F18 | -- | -- | -- |
| holding | Class A Common Stock F19 | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (19)
- F1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.36 to $34.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $34.40 to $34.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.90 to $33.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $30.87 to $31.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F6. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $31.87 to $32.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F7. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.38 to $33.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- F8. The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
- F9. The shares held by CV VII Hldgs as reported herein reflect pro rata distributions in kind, effected by CV VII Hldgs to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
- F10. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F11. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
- F12. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F13. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
- F14. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F15. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
- F16. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- F17. The shares reported herein reflect the receipt of shares pursuant to a pro rata distribution in kind, effected by CB VII, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
- F18. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
- F19. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
Key Figures
Key Terms
weighted average price financial
pro rata distributions in kind financial
Rule 16a-13 regulatory
pecuniary interest financial
irrevocable trust financial
revocable trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Chime Financial (CHYM) director James Feuille report in this Form 4?
What CHYM holdings does James Feuille report after these transactions?
Does this CHYM Form 4 indicate trades under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.